Skip to main content
. 2021 Feb 18;9(2):207. doi: 10.3390/biomedicines9020207

Figure 7.

Figure 7

Low expression of both BECN1 and BRCA1 in conjugation gives better and longer overall survival as well as disease-free survival. (A) Overall survival for HGSOC patients according to BECN1 and BRCA1 expression level (H/H, H/L, L/H and L/L). (B) Disease-free survival for HGSOC patients according to BECN1 and BRCA1 expression level (H/H, H/L, L/H and L/L). (C) Box-plot showing the distribution of BECN1 according to expression level (high and low). (D) Box-plot showing the distribution of BRCA1 according to expression level (high and low). (Note that for OS data were not available for 1 patient (L/L group 1 pt: 225 pt’s; L/L group total n = 226 pt’s) while for DFS data were missing for 49 patients (H/H group 3 pt’s: 5 + H/L group 10 pt’s: 15 pt’s + L/H group 6 pt’s: 18 pt’s + L/L group 34 pt’s: 192; total n = 279 pt’s), respectively).